CEO Monthly Issue 12 2018

16 CEO MONTHLY / ISSUE 12 2018 , Grows revenue by 120 percent; Includes 6 of top 10 pharma on client list; Adds industry veterans to guide future growth. AiCure’s revenue soars as it bolsters client list and executive team AiCure, a behavioral data analytics company targeting the healthcare and life sciences industries, today announced its revenue growth more than doubled year-over-year from 2017. This growth comes from a significant client increase – having added eight leading biotechnology and pharmaceutical clients to its roster over the past year. In addition, AiCure added four industry veterans to its management and board of directors teams. With these milestones, AiCure will continue to deliver on its commitment to improve health by understanding the science behind the human response to illness and treatment. “The application of AI is starting to make its mark in healthcare, and the industry is beginning to see its unlimited potential,” said Adam Hanina, co-founder and CEO of AiCure. “At AiCure, we’re committed to improving patients’ health worldwide by leveraging innovative AI-enabled technology that sees, hears and understands behavior. With our strong customer partnerships and experienced executive leadership team, we are one step closer to achieving that goal and continuing our momentum into 2019.” Business Growth Over the past year, AiCure increased its revenue growth by 120 percent and bookings by 150 percent, as well as expanded its client list by more than 30 percent from 2017. Now, the company works with six of the top 10 pharmaceutical companies and 11 of the top 30 pharmaceutical companies globally. Personnel Growth Along with expanding its client portfolio, AiCure grew its workforce by 189 percent and built upon its existing executive team’s industry-leading expertise with the following additions: Edward Ikeguchi, M.D., joined as Chief Medical Officer. Dr. Ikeguchi was previously a co-founder and Chief Medical Officer at Medidata for nearly a decade, where he helped grow the company from inception to its IPO in 2009. Jindra Zitek, joined as Chief Operating Officer. Zitek has over 20 years of experience in operational strategy and was formerly with McKinsey, TPG and CIO of Chobani. Isaac Galatzer-Levy, Ph.D., onboarded as Vice President of Clinical and Computational Neuroscience and Director of AiCure Labs. Dr. Galatzer- Levy’s background is in machine learning, neuroscience, and clinical psychology. Dr. Galatzer- Levy has lead large teams of researchers, received NIH, DOD, and foundation funding, published in over 75+ peer- reviewed publications, and has contributed significantly to the emerging field of digital mental health. Gary Velasquez, CEO of Cogitativo, joined the company’s board of directors. Velasquez has more than 30 years of executive management experience in healthcare services and driving shareholder value. For more information about AiCure and its platform, visit www.aicure.com.